AAAAAA

   
Results: 1-8 |
Results: 8
EFFECT OF ZAFIRLUKAST (ACCOLATE) ON CELLULAR MEDIATORS OF INFLAMMATION - BRONCHOALVEOLAR LAVAGE FLUID FINDINGS AFTER SEGMENTAL ANTIGEN CHALLENGE
Authors: CALHOUN WJ LAVINS BJ MINKWITZ MC EVANS R GLEICH GJ COHN J
Citation: Wj. Calhoun et al., EFFECT OF ZAFIRLUKAST (ACCOLATE) ON CELLULAR MEDIATORS OF INFLAMMATION - BRONCHOALVEOLAR LAVAGE FLUID FINDINGS AFTER SEGMENTAL ANTIGEN CHALLENGE, American journal of respiratory and critical care medicine, 157(5), 1998, pp. 1381-1389
THE LEUKOTRIENE RECEPTOR ANTAGONIST ZAFIRLUKAST INHIBITS SULFUR DIOXIDE-INDUCED BRONCHOCONSTRICTION IN PATIENTS WITH ASTHMA
Authors: LAZARUS SC WONG HH WATTS MJ BOUSHEY HA LAVINS BJ MINKWITZ MC
Citation: Sc. Lazarus et al., THE LEUKOTRIENE RECEPTOR ANTAGONIST ZAFIRLUKAST INHIBITS SULFUR DIOXIDE-INDUCED BRONCHOCONSTRICTION IN PATIENTS WITH ASTHMA, American journal of respiratory and critical care medicine, 156(6), 1997, pp. 1725-1730
THE LEUKOTRIENE D-4-RECEPTOR ANTAGONIST, ICI-204,219, RELIEVES SYMPTOMS OF ACUTE SEASONAL ALLERGIC RHINITIS
Authors: DONNELLY AL GLASS M MINKWITZ MC CASALE TB
Citation: Al. Donnelly et al., THE LEUKOTRIENE D-4-RECEPTOR ANTAGONIST, ICI-204,219, RELIEVES SYMPTOMS OF ACUTE SEASONAL ALLERGIC RHINITIS, American journal of respiratory and critical care medicine, 151(6), 1995, pp. 1734-1739
ONSET OF ACTION OF THE LEUKOTRIENE-RECEPTOR ANTAGONIST, ZAFIRLUKAST (ACCOLATE(TM)), IN PATIENTS WITH ASTHMA
Authors: KEMP JP GLASS M MINKWITZ MC
Citation: Jp. Kemp et al., ONSET OF ACTION OF THE LEUKOTRIENE-RECEPTOR ANTAGONIST, ZAFIRLUKAST (ACCOLATE(TM)), IN PATIENTS WITH ASTHMA, Journal of allergy and clinical immunology, 95(1), 1995, pp. 351-351
EFFECTS OF 6 WEEKS OF THERAPY WITH ORAL DOSES OF ICI-204,219, A LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, IN SUBJECTS WITH BRONCHIAL-ASTHMA
Authors: SPECTOR SL SMITH LJ GLASS M BIRMINGHAM BK BRONSKY EA DUNN KD FISH JE GROSSMAN J HOWLAND W MINKWITZ MC LARSEN JS NATHAN RA RENNARD SI SCHULMAN ES SEGAL A SELTZER LM
Citation: Sl. Spector et al., EFFECTS OF 6 WEEKS OF THERAPY WITH ORAL DOSES OF ICI-204,219, A LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, IN SUBJECTS WITH BRONCHIAL-ASTHMA, American journal of respiratory and critical care medicine, 150(3), 1994, pp. 618-623
6-WEEK THERAPY WITH THE ORAL LEUKOTRIENE-RECEPTOR ANTAGONIST, ICI-204,219, IN THE TREATMENT OF ASTHMA
Authors: HOWLAND W SEGAL A GLASS M MINKWITZ MC
Citation: W. Howland et al., 6-WEEK THERAPY WITH THE ORAL LEUKOTRIENE-RECEPTOR ANTAGONIST, ICI-204,219, IN THE TREATMENT OF ASTHMA, Journal of allergy and clinical immunology, 93(1), 1994, pp. 259-259
INHALED ICI-204,219 BLOCKS ANTIGEN-INDUCED BRONCHOCONSTRICTION IN SUBJECTS WITH BRONCHIAL-ASTHMA
Authors: NATHAN RA GLASS M MINKWITZ MC
Citation: Ra. Nathan et al., INHALED ICI-204,219 BLOCKS ANTIGEN-INDUCED BRONCHOCONSTRICTION IN SUBJECTS WITH BRONCHIAL-ASTHMA, Chest, 105(2), 1994, pp. 483-488
INHIBITION OF LEUKOTRIENE D(4)-INDUCED BRONCHOCONSTRICTION IN SUBJECTS WITH ASTHMA - A CONCENTRATION-EFFECT STUDY OF ICI-204,219
Authors: SMITH LJ GLASS M MINKWITZ MC
Citation: Lj. Smith et al., INHIBITION OF LEUKOTRIENE D(4)-INDUCED BRONCHOCONSTRICTION IN SUBJECTS WITH ASTHMA - A CONCENTRATION-EFFECT STUDY OF ICI-204,219, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 430-436
Risultati: 1-8 |